Detalles de la búsqueda
1.
Exploratory analysis to identify the best antigen and the best immune biomarkers to study SARS-CoV-2 infection.
J Transl Med
; 19(1): 272, 2021 06 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-34174875
2.
Multi-omics approach to COVID-19: a domain-based literature review.
J Transl Med
; 19(1): 501, 2021 12 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-34876157
3.
Epidemic and pandemic viral infections: impact on tuberculosis and the lung: A consensus by the World Association for Infectious Diseases and Immunological Disorders (WAidid), Global Tuberculosis Network (GTN), and members of the European Society of Clinical Microbiology and Infectious Diseases Study Group for Mycobacterial Infections (ESGMYC).
Eur Respir J
; 56(4)2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32586885
4.
Probiotics Differently Affect Gut-Associated Lymphoid Tissue Indolamine-2,3-Dioxygenase mRNA and Cerebrospinal Fluid Neopterin Levels in Antiretroviral-Treated HIV-1 Infected Patients: A Pilot Study.
Int J Mol Sci
; 17(10)2016 Sep 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-27689995
5.
Initial immune response after exposure to Mycobacterium tuberculosis or to SARS-COV-2: similarities and differences.
Front Immunol
; 14: 1244556, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37662901
6.
Antigen discovery by bioinformatics analysis and peptide microarray for the diagnosis of cystic echinococcosis.
PLoS Negl Trop Dis
; 17(4): e0011210, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-37043489
7.
Alternative biomarkers of tuberculosis infection in patients with immune-mediated inflammatory diseases.
Front Med (Lausanne)
; 10: 1271632, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-38076244
8.
Characterization of the immune impairment of patients with tuberculosis and COVID-19 coinfection.
Int J Infect Dis
; 130 Suppl 1: S34-S42, 2023 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-36944383
9.
Persistent Spike-specific T cell immunity despite antibody reduction after 3 months from SARS-CoV-2 BNT162b2-mRNA vaccine.
Sci Rep
; 12(1): 6687, 2022 04 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-35461335
10.
Evaluation of the immunomodulatory effects of interleukin-10 on peripheral blood immune cells of COVID-19 patients: Implication for COVID-19 therapy.
Front Immunol
; 13: 984098, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36148228
11.
In Vitro Models for Studying Entry, Tissue Tropism, and Therapeutic Approaches of Highly Pathogenic Coronaviruses.
Biomed Res Int
; 2021: 8856018, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34239932
12.
Accuracy of an experimental whole-blood test for detecting reactivation of echinococcal cysts.
PLoS Negl Trop Dis
; 15(8): e0009648, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34415898
13.
Spike is the most recognized antigen in the whole-blood platform in both acute and convalescent COVID-19 patients.
Int J Infect Dis
; 106: 338-347, 2021 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-33864921
14.
Cysteamine with In Vitro Antiviral Activity and Immunomodulatory Effects Has the Potential to Be a Repurposing Drug Candidate for COVID-19 Therapy.
Cells
; 11(1)2021 12 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-35011614
15.
In-vitro evaluation of the immunomodulatory effects of Baricitinib: Implication for COVID-19 therapy.
J Infect
; 82(4): 58-66, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33639176
16.
Impact of Prior Influenza and Pneumoccocal Vaccines on Humoral and Cellular Response to SARS-CoV-2 BNT162b2 Vaccination.
Vaccines (Basel)
; 9(6)2021 Jun 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34201065
17.
A whole blood test to measure SARS-CoV-2-specific response in COVID-19 patients.
Clin Microbiol Infect
; 27(2): 286.e7-286.e13, 2021 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-33045370
18.
ImmunosuppressiveTherapies Differently Modulate Humoral- and T-Cell-Specific Responses to COVID-19 mRNA Vaccine in Rheumatoid Arthritis Patients.
Front Immunol
; 12: 740249, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34594343
19.
Direct-acting antiviral therapy enhances total CD4+ and CD8+ T-cells responses, but does not alter T-cells activation among HCV mono-infected, and HCV/HIV-1 co-infected patients.
Clin Res Hepatol Gastroenterol
; 42(4): 319-329, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-29279268
Resultados
1 -
19
de 19
1
Próxima >
>>